CAMBRIDGE, Mass., May 22, 2014 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced it will present clinical data on four novel antibody cancer therapeutics at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting, May 30-June 3, 2014 at McCormick Place in Chicago. These presentations showcase Merrimack's broad oncology pipeline.
Help employers find you! Check out all the jobs and post your resume.
